Basics Janux Therapeutics, Inc. IPO Date: June 11, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.52B Activated in VL: True Average Daily Range Avg Daily Range: $0.86 | 3.70% Avg Daily Range (30 D): $0.51 | 2.00% Avg Daily Range (90 D): $0.68 | 2.55% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .56M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 1,301 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $2.1M Avg Inst. Trade (90 D): $1.86M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $3.54M Avg Closing Trade (30 D): $3.04M Avg Closing Trade (90 D): $2.85M Avg Closing Volume: 93.39K     News Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research Apr 30, 2024 @ 12:50 PM Here's What Could Help Janux Therapeutics (JANX) M... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.35 $-.38 $-.35 Diluted EPS $-1.35 $-.38 $-.35 Revenue $ 9.34M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -77.74M $ -23.51M $ -20.22M Operating Income / Loss $ -113.58M $ -34.9M $ -29.02M Cost of Revenue $ $ $ Net Cash Flow $ -139.06M $ -356.86M $ 403.85M PE Ratio